Reliance Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 16 Oct 2017 138.65 1.68
(1.23%)

NAV High-Low (in Rs)

ONE Mth 1581.07
1581.07
52-WEEk 1235.15
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 2.24 3.6 - - 5.93
Sensex 2.14 1.04 10.86 18.45 24.9
Nifty 2.17 1.48 11.98 20.12 31.55

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 30 Sep 2017
Category Share (%)
Cash & Cash Equivalent 0.00
Derivatives 0.43
Equity 96.59
Net CA & Others 0.20
Reverse Repo 2.78
› More
   As On 30 Sep 2017
Sector Name Amount
Finance & Investments 2.51
Healthcare 12.59
NA 3.41
Pharmaceuticals - Indian - Bulk Drugs 17.23
Pharmaceuticals - Indian - Bulk Drugs & Formln 47.63
Pharmaceuticals - Multinational 16.63
› More
   As On 30 Sep 2017
Company Name
Divi's Lab. 10.82
Dr Reddy's Labs 9.88
Sun Pharma.Inds. 9.23
Cipla 9.09
Abbott India 8.57
Aurobindo Pharma 8.31
Sanofi India 8.06
Thyrocare Tech. 6.63
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-33031000/30301111 | Fax: 022-33037662

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com